
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79624 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Polyallylamine Hydrochloride (2-Propen-1-amine, hydrochloride (1:1), homopolymer)
CAS:Polysulfides, polysulfones & oth products spec in note 3, chapter 39, except elastomericFormula:(C3H7N)n·nHClColor and Shape:White Light Yellow PowderMolecular weight:93.55 g/molPrimaquine Related Compound A (8-[(4-Aminopentyl)amino]-6-methoxyquinoline)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C15H21N3OColor and Shape:Yellow Brown SolidMolecular weight:259.16846Dihydrodutasteride (N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide)
CAS:Lactams not elsewhere specified or includedFormula:C27H32F6N2O2Color and Shape:White SolidMolecular weight:530.2368Temozolomide Related Compound A (4-diazo-4H-imidazole-5-carboxamide)
CAS:Compounds containing an unfused imidazole ring (whetherFormula:C4H3N5OColor and Shape:PowderMolecular weight:137.03376Argatroban
CAS:Sulfonamides used as drugsFormula:C23H36N6O5S·H2OColor and Shape:White Off-White PowderMolecular weight:526.25735Temazepam Related Compound G (7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione)
CAS:Heterocyclic compounds (excluding aromatic or modifiedFormula:C17H15ClN2O2Color and Shape:PowderMolecular weight:314.08221Clopidogrel Bisulfate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White Off-White PowderMolecular weight:321.05903Rivastigmine Related Compound F (3-Vinylphenyl ethyl(methyl)carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C12H15NO2Color and Shape:Colorless LiquidMolecular weight:205.11028Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H17N3O4·HClColor and Shape:Off-White SolidMolecular weight:327.09858Trandolapril Related Compound D ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C24H32N2O4Color and Shape:White Crystalline PowderMolecular weight:412.23621Cyclosporine
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White PowderMolecular weight:1201.84137Formyl Penicillamine (2-Formamido-3-mercapto-3-methylbutanoic acid)
CAS:Organo-sulfur compounds, nesoiFormula:C6H11NO3SColor and Shape:White PowderMolecular weight:177.04596Sibutramine Related Compound D (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or includedFormula:C16H24ClN·HClColor and Shape:PowderMolecular weight:265.15973Anhydro Simvastatin ((1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS:Lactones nesoiFormula:C25H36O4Color and Shape:Off-White PowderMolecular weight:400.55Amrinone Related Compound C (6-Oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile)
CAS:Lactams, nesoiFormula:C11H7N3OColor and Shape:Tan Off-White PowderMolecular weight:197.05891Famotidine Related Compound D (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C8H13N5OS2Color and Shape:White PowderMolecular weight:259.05615Myristylpyridinium Chloride (1-Tetradecylpyridinium chloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C19H34ClNColor and Shape:White Off-White PowderMolecular weight:311.23798Granisetron Related Compound E ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C9H18N2·C2H4O2Color and Shape:Off-White PowderMolecular weight:154.147Citalopram Related Compound E (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C20H21FN2O2·HClColor and Shape:White PowderMolecular weight:340.15871Norelgestromin Related Compound A (13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-5(6)-en-20-yn-3-one oxime)
CAS:Estrogens and progestinsFormula:C21H29NO2Color and Shape:SolidMolecular weight:327.21983

